STEM Symposium: GMP Considerations for Cell and Gene Therapy

Join us virtually on September 26 at 12 p.m. ET to learn more about the various types of cell and gene therapies available on the market and good manufacturing practice (GMP) considerations that need to be addressed for autologous therapies (like CAR-T cells) and their manufacture and distribution to patients.